Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      28 trials found for solid tumor

      Recruiting
      Not yet recruiting
      2 trials recruiting
      Pfizer Breast Cancer Clinical Trials

      Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

      2 trials recruiting
      Be6A Clinical Trials

      Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.

      Recruiting
      NCT05355701
      A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

      Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma

      Male or Female
      16+ years
      38study location(s)
      Recruiting
      NCT06758401
      This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

      Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)

      Male or Female
      18+ years
      22study location(s)
      Recruiting
      NCT03460977
      Mevrometostat Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

      Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)

      Male or Female
      18+ years
      50study location(s)
      Recruiting
      NCT06799533
      A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

      Malignant Melanoma, Melanoma, Metastatic Melanoma, Solid Tumors

      Male or Female
      18+ years
      9study location(s)
      Recruiting
      NCT05983133
      A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

      Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Pancreatic Ductal Adenocarcinoma

      Male or Female
      18+ years
      23study location(s)
      Recruiting
      NCT06704724
      A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

      Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung

      Male or Female
      18+ years
      14study location(s)
      Recruiting
      NCT05208762
      A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

      Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Ovarian Neoplasms, Melanoma, Triple Negative Breast Neoplasms, Gastric Cancer

      Male or Female
      18+ years
      45study location(s)
      Recruiting
      NCT04389632
      A Study of Sigvotatug Vedotin in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      50study location(s)
      Recruiting
      NCT04879329
      A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      50study location(s)
      Recruiting
      NCT05911295
      Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      50study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.